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Abstract
Background: Periodontal disease and diabetes mellitus are common, chronic
diseases worldwide. Epidemiologic and biologic evidence suggest periodontal dis-
ease may affect diabetes.
Objective: To systematically review non-experimental, epidemiologic evidence for
effects of periodontal disease on diabetes control, complications and incidence.
Data sources: Electronic bibliographic databases, supplemented by hand searches
of recent and future issues of relevant journals.
Study eligibility criteria and participants: Longitudinal and cross-sectional epide-
miologic, non-interventional studies that permit determination of directionality of
observed effects were included.
Study appraisal and synthesis methods: Four reviewers evaluated pair-wise each
study. Review findings regarding study results and quality were summarized in
tables by topic, using the PRISMA Statement for reporting and the Newcastle-
Ottawa System for quality assessment, respectively. From 2246 citations identified
and available abstracts screened, 114 full-text reports were assessed and 17
included in the review.
Results: A small body of evidence supports significant, adverse effects of peri-
odontal disease on glycaemic control, diabetes complications, and development of
type 2 (and possibly gestational) diabetes.
Limitations: There were only a limited number of eligible studies, several of
which included small sample sizes. Exposure and outcome parameters varied, and
the generalizability of their results was limited.
Conclusions and implications of key findings: Current evidence suggests that peri-
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Periodontal diseases, including the
reversible form gingivitis, affect up to
90% of the world’s population (Pihl-
strom et al. 2005). While “dental car-
ies of permanent teeth” tops the
Global Burden of Disease (GBD) list
with an estimated prevalence of
35.3%, chronic periodontitis (10.8%)
follows with only headache/migraine
and skin diseases between (Vos et al.
2013). Periodontitis is reported to
affect half of adults (Hu et al. 2011,
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Eke et al. 2012a, Patel & Platform
for Better Oral Health in Europe,
2012) or more (Holtfreter et al.
2010), with the severe form periodon-
titis affecting around 10% (range: 5–
20%) of adults (Petersen et al. 2005,
Dye et al. 2007, Eke & Dye 2009,
Holtfreter et al. 2009, Mattila et al.
2010, Eke et al. 2012a, Patel 2012,
White et al. 2012) and moderate peri-
odontitis around one-third (Holtfr-
eter et al. 2009, Eke et al. 2012a,
White et al. 2012). In aged popula-
tions and in indigenous people, the
prevalence of periodontitis is even
higher: It is reported that 70–90% of
individuals aged 60–74 years (Holtfr-
eter et al. 2010, Mattila et al. 2010,
Patel 2012) and indigenous people
(Brothwell & Ghiabi 2009) suffer
from periodontitis. It is noteworthy
the actual prevalence of periodontitis
may be substantially higher than
hitherto reported. This is due to
underestimation by prior population
surveys due to their use of partial
mouth recordings and reliance on
only periodontal probing depth
instead of clinical attachment level
(Albandar & Rams 2002, Eke et al.
2010, 2012b, Beltran-Aguilar et al.
2012, White et al. 2012).
It is estimated that 346 million
people have diabetes worldwide
(World Health Organization 2011)
with the prediction of 439 million by
the year 2030, representing an
increase of 54% in 20 years to encom-
pass almost one tenth of adults
20 years and older (Chen et al. 2012).
In addition, according to the Global
Burden of Disease study, diabetes is a
major cause of years lived with dis-
ability (YLD), estimated at 20.8 mil-
lion YLDs. Diabetes is ranked as the
ninth most common disorder in the
world, amassing a 67.2% increase
over the 20 years from 1990 to 2010
(Vos et al. 2013).
From a global perspective, although
the prevalence of diabetes is high in the
industrialized countries – with for
example 11.3% (25.8 million) of the
US population already having diabetes
(Centers for Disease Control & Preven-
tion 2011) – it is worth emphasizing
that over 80% of diabetes patients live
in low- and middle-income countries
(World Health Organization 2011),
with the Middle East encompassing
six of the ten countries with the high-
est prevalence (International Diabetes
Federation 2011).
Currently, there is increasing inter-
est in links between periodontal dis-
ease and non-oral, systemic,
inflammatory-related diseases and
conditions, such as atherosclerotic
cerebro-cardiovascular conditions
and events (Kebschull et al. 2010,
Ylöstalo et al. 2010, Borgnakke 2012,
Lockhart et al. 2012). The biologic
plausibility supporting such connec-
tion is based on the fact that inflam-
matory periodontal disease due to
reaction to pathogenic biofilm stimu-
lates a chronic systemic inflammation
and thus contributes to the cumula-
tive inflammatory burden in the host
(Loos 2005, Renvert et al. 2006).
Inflammation precedes diabetes onset
(Duncan et al. 1999, Schmidt et al.
1999, Duncan & Schmidt 2006) and is
linked to insulin resistance and devel-
opment of diabetes (Wang et al.
2013) as well as its complications
(King 2008). Since effective therapy
and management of periodontal dis-
ease are well established, it is impor-
tant to know for future prevention
and control of diabetes whether peri-
odontitis indeed plays a role in the
development and control of diabetes
and its potentially fatal complications
(Lalla & Papapanou 2011).
If such a causal relation indeed
exists, a new paradigm in dental and
medical standard of care for screen-
ing, prevention and management of
diabetes could be developed in the
future. Close collaboration among
each patient’s health care profession-
als would be warranted, especially
among medical and dental care pro-
viders (Glurich et al. 2013).
Review of Current Literature
Objective
Our aim was to conduct a systematic
review to identify and evaluate the
scientific evidence from epidemiolo-
gic, non-experimental, observational
studies of effects of periodontal dis-
ease on diabetes mellitus. Specifically,
we explored effects on glycaemic con-
trol, the development of complica-
tions and the onset of diabetes. Study
populations should consist of individ-
uals without diabetes and with known
types 1 and 2 diabetes, in addition to
pregnant women with and without
gestational diabetes.
The specific questions addressed in
this systematic review were:
1. Do people with manifest type 2
diabetes, pre-diabetes or no
known diabetes, who have poorer
periodontal health, have poorer
glycaemic control than those with
better periodontal health?
2. Do people with type 1 diabetes,
who have poorer periodontal
health, have poorer glycaemic
control than those with better
periodontal health?
3. Do people with diabetes, who have
poorer periodontal health, have
more diabetes complications than
those with better periodontal health?
4. Do people without known diabetes,
who have poorer periodontal health,
have greater risk for developing
(incident) type 2 diabetes than those
with better periodontal health?
5. Do women with gestational dia-
betes, who have poorer periodon-
tal health, have poorer glycaemic
control than those with better
periodontal health?
6. Do pregnant women, who have
poorer periodontal health, have
greater risk for gestational diabe-
tes than those with better peri-
odontal health?
Only reported findings from origi-
nal, epidemiologic, non-intervention,
observational studies of longitudinal,
case-control or cross-sectional designs
were eligible for inclusion in this
review. They needed to include differ-
ent categories of periodontal disease
(exposure) and at least one parameter
related to diabetes (outcome).
Methods
Protocols
The Preferred Reporting Items for
Systematic Reviews and
Meta-Analyses (PRISMA)
For describing and summarizing the
results of our review, we used the 27
Preferred Reporting Items for System-
atic Reviews and Meta-Analyses
(PRISMA Statement; www.prisma
statement.org) (Moher et al. 2009a,b).
The Newcastle-Ottawa Scale for
assessing the quality of non-random-
ized studies (NOS)
Assessment of the quality of non-
randomized, non-interventional stud-
ies is essential for proper evaluation
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of the evidence provided by each
study. We followed the Newcastle-
Ottawa System (NOS) protocol
(Wells et al. 2011). The scale is
described and the forms used dis-
played in the online appendix,
Exhibits Appendix S6 and Appendix
S7–S9 respectively.
Eligibility criteria
We limited our search to original
research reports on periodontal
disease and diabetes that were
conducted in humans and reported
in English in any year.
Information sources
We searched electronic databases
and hand searched bibliographies of
already identified reports, as well as
online sites with reports accepted for
publication ahead of print for the
most relevant scientific journals. We
also created automated electronic
alerts for identification of additional
reports. In addition, we contacted
authors for clarification and addi-
tional information regarding three
papers. We conducted the last com-
prehensive search on July 26, 2012,
but ensured by the last search on
January 6, 2013, that no additional
eligible reports were catalogued in
PubMed. While imposing the limits
Humans and English language, we
searched the following bibliographic
databases:
• PubMed, incl. MEDLINE and
Pre-MEDLINE, by OVID (from
1950)
• Web of Science by Thomson
Reuters
• EMBASE by Elsevier via OVID
(from 1980)
• Dentistry and Oral Sciences
SourceTM by EBSCO via OVID
• CINAHL by EBSCO (from
1937)
• Evidence Based Medicine (EBM)
Reviews
• SciVerse by Elsevier
• LILACS (Latin American and
Caribbean Health Sciences) by
Virtual Health library (from
1982)
Further details regarding these
databases searched are provided in
Appendix S1.
Literature search
We searched the different databases
using as identical search strategies as
possible within the rules of each
database. As an example, the main
PubMed search query follows, in
which “tiab” means the terms may
be found in the title, the abstract or
both: (“periodontal diseases”[mh]
OR periodontium[mh] OR periodon-
tics[mh] OR periodont*[tiab]) AND
(“diabetes mellitus”[mh] OR “diabe-
tes insipidus”[mh] OR diabet*[tiab]
OR “dm 1”[tiab] OR “dm i”[tiab] OR
“dm 2”[tiab] OR “dm ii”[tiab] OR
“hemoglobin a, glycosylated”[mh]
OR a1c[tiab] OR “hb a1c”[tiab]
OR hba1c[tiab] OR “blood glu-
cose”[mh] OR “blood sugar”[tiab]
OR ((glucose[ti] OR sugar[ti])
AND (level[ti] OR control[ti])) OR
hyperglycemia[mh] OR hypoglyce-
mia[mh] OR glycemi*[tiab] OR
glycaemi*[tiab] OR hyperglyc*[tiab]
OR hypoglyc*[tiab]). Filters used
were: Humans and English
language.
It was confirmed that addition of
the UK spelling of the key search
terms provided results identical to
the search using US spelling alone.
In addition to the example shown,
this was ensured by extra searches
using the term “haemoglobin.”
The electronic bibliographic refer-
ence manager program EndNote,
version X6, by Thomson Reuters
(http://endnote.com/) was used to
identify duplicates; screen citations
and abstracts; categorize citations in
ineligible and eligible groups; create
lists of citations for tables; and
create the in-text citations and the
bibliography.
Study selection
We identified 4990 citations that
included the search terms, amounting
to 2246 unique citations after identi-
fying and removing duplicate
records. Two of the authors reviewed
the 2246 citations and their abstracts
and selected 114 reports for reading
of the full text. The four reviewers
read the papers in alternating pairs,
so that each reviewer read half (57)
papers each, but with different part-
ners. Hence, each report was scored
independently by two reviewers. In
case of discrepancies, all four review-
ers were asked to review the papers,
without knowledge of the other
reviewers’ decisions. All four review-
ers arrived at a final, mutual agree-
ment of scoring each paper based on
discussions during frequent telephone
conference calls. This procedure was
followed for both classification of
eligibility and quality of reports
deemed eligible for inclusion.
We selected reports on original
epidemiologic, non-interventional,
observational (descriptive and ana-
lytical) studies that concerned
parameters on periodontal disease
and glycaemic control or blood con-
centrations of glucose among people
without diabetes or with any kind of
diabetes (no pathological elevation
in blood glucose concentration, pre-
diabetes (impaired fasting glucose),
types 1 or 2 diabetes and gestational
diabetes). For cohort and case-
control studies, it must be evident
that the topic studied was the effect
of periodontal disease on diabetes,
that is, the report results must per-
mit determination of directionality.
In addition, cross-sectional studies
were eligible for inclusion, but only
if they reported on associations
between periodontal disease (expo-
sure) and diabetes parameters (out-
comes) that were unlikely to cause
periodontitis, such as the diabetes
complications retinopathy and neu-
ropathy, to ensure determination of
directionality.
Data collection process
We developed forms for scoring each
report as well as for the logistic
administration, logging and track
keeping of papers to retrieve and to
review. One reviewer (WSB) assumed
the administrative tasks in addition
to the full reviewer tasks and created
a Master file with the 114 citations
that were numbered for unambiguous
identification. This Master file was
used to identify the assignments of
reports among the four reviewers, to
enter the scores from each reviewer
as they became available, and to
identify discrepancies between the
duplicate reviewers’ categorization.
Subsequently, the Master file would
be used for tallying the number of
reports in the different categories of
eligibility and ineligibility.
Prior to actual scoring, the rating
forms were tested by all reviewers by
trial scoring 21 relevant papers that
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the administrative reviewer already
had available before the actual sys-
tematic search. The scoring forms
were discussed and revised in an iter-
ative process until all four reviewers
agreed on the final format.
The data extraction was per-
formed in duplicate with two review-
ers independently assessing each
report, determining eligibility and
indicating reasons for ineligibility.
First, each reviewer decided on a
study’s eligibility for inclusion in the
systematic review, based on the
reported parameters. At this point,
the reviewer made no quality assess-
ment of the study. Each report
deemed ineligible for inclusion was
categorized in a hierarchical manner
according to one of the following
main reasons for its exclusion:
Main Exclusion Reasons (in
Hierarchally Prioritized Order):
N1. Not original study (review,
guidelines, comment)
N3. Original, but not epidemiolo-
gic study
N4. Original, but interventional
study
N2. Original study, but not on
effect of periodontal disease
on glycaemic control
N5. Other reason.
The ineligible study was recorded
with the exclusion reasons on the form
displayed in Exhibit Appendix S2.
Second, the reports deemed eligi-
ble were categorized into one of the
following groups:
Eligibility Categories for Effect of
Periodontal Disease on:
E1. Glycaemic control in:
E1a. Type 2 diabetes
E1b. Pre-diabetes
E1c. No known diabetes
E2. Glycaemic control in type 1
diabetes
E3. Diabetes-related complications
E6. Incident type 2 diabetes (new
diabetes developed in individ-
uals without diabetes at base-
line)
E4. Gestational diabetes control
E5. Risk for [development of]
gestational diabetes
Third, data were extracted from
each paper by each reviewer who
recorded the findings on the data
collection form displayed as Exhibit
Appendix S4.
Data items
Regardless of study design, we col-
lected the following information, with
the majority of data points equipped
with standard response categories
with the option for open-ended
responses: Study Design, Population
Based, Study Duration, # Subjects,
Sex, Age, DM Type, DM outcomes
assessed, DM Measured/Diagnosed,
DM Control Definition/Groups,
Other DM-Related Measures, Type
of Periodontal Examination, Peri-
odontal Measures, Periodontal Case
Definition/Groups, Examiner Cali-
bration, Analysis, Effect of Perio on
DM, Effect: Parameter & Size, Dose–
Response Effect, Main Findings and
Comments (Medication use; Comor-
bidity, etc.), Exhibit Appendix S4.
Risk of bias in individual studies
As mentioned, we assessed the
quality of each cohort and case-
control study according to NOS for
Assessing the Quality of Non-ran-
domized Studies (Wells et al. 2011),
described in Exhibit Appendix S6,
but devised an additional scale for
rating cross-sectional studies. The
NOS evaluates three dimensions of
a study, namely A) selection of the
study groups; B) comparability of
the study groups; and C) ascertain-
ment of either the exposure or out-
come of interest. We developed one
form for each of the three study
designs: cohort, case-control and
cross-sectional. The three forms are
displayed as Exhibits Appendix
S7–S9.
Using these forms, we rated each
report at both the study and outcome
levels.
Summary measures
The majority of studies reported
results using odds ratios (OR), haz-
ard ratios (HR) and hazard rate
ratios (HRR), but also other relative
risks measures, such as risk ratios,
rate ratios or relative risks.






















Addi onal records iden fied 
through other sources
(n = 440)
Records a er duplicates removed
(n = 2,246) 
Full-text ar cles assessed 
for eligibility
(n = 113 papers/114 studies)
Records excluded based 
on full text ar cles
(n = 97)
Studies included in 
qualita ve synthesis
(n = 16 papers/17 studies) 
Cita ons & abstracts 
screened
(n = 2,246)
Records excluded based 
on cita on & abstract
(n = 2,133)
Main Reasons for Exclusions:
Not original study (review, guidelines, le er, 
comments) (n = 7)
Original, but not epidemiologic study (n = 10)
Original, but interven onal study (n = 5)
Original study, but not on perio=>DM (n = 75)
·
···
Fig. 1. Selection of studies for systematic review of epidemiologic observational evidence
for the effect of periodontal disease on diabetes control, complications and incidence.
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Synthesis of results
Due to the small number of studies
for each topic and their pronounced
heterogeneity with regard to their
design and outcome measures, their
data could not be pooled and meta-
analyses conducted. Instead, findings
from each study were described
together with the remaining studies
on the same topic, with one Table
for each original question posed.
Risk of bias across studies
As with other bodies of scientific evi-
dence, the potential effect of publica-
tion bias, favouring reporting of
positive outcomes, cannot be
excluded. Likewise, it is not known
whether the authors reported only
their most favourable results.
Additional analyses
Pre-review knowledge of the limited
scope of the existing evidence pre-
vented pre-specification of any addi-




A total of 2246 unique citations were
identified. The numbers of studies
screened, assessed for eligibility,
undergoing reading of full text, and
included in the final review are
shown in Fig. 1. Table 1 displays the
final 16 papers selected for the
review that yielded results from 17
studies, as one report included find-
ings for two different outcomes (Sai-
to et al. 2004). The citations for the
97 reports excluded upon full text
perusing are displayed in Exhibit
Appendix S3, along with the main
reason for exclusion of each paper.
Exhibit Appendix S5 lists the 17
reports included in the final review.
Description of characteristics, results and
quality of each study
The findings from this review are
described in the following for each
of the originally posed questions.
For each topic, a table displays the
characteristics and findings from
each study, and a brief summary is
provided of only the longitudinal
results, that is, any cross-sectional
findings at baseline are not shown.
Importantly, all confounders for
which the analyses are controlled are
displayed for each outcome or
model, respectively, in Tables 2–5
under the heading “Confounders
Controlled.” In consideration of
space and readability, these con-
founders will not be re-cited in the
text. Risk of bias within and across
studies is addressed briefly and the
consensus NOS quality scores for
each study are displayed in the
online Appendix, with such tables
Table 1. The 16 reports (on 17 studies) included in the final review: citations
1. Abrao, L., Chagas, J. K. & Schmid, H. (2010) Periodontal disease and risk for neuropathic foot ulceration in type 2 diabetes. Diabetes
Res Clin Pract 90, 34–39. doi:10.1016/j.diabres.2010.06.014.
2. Dasanayake, A. P., Chhun, N., Tanner, A. C., Craig, R. G., Lee, M. J., Moore, A. F. & Norman, R. G. (2008) Periodontal pathogens
and gestational diabetes mellitus. J Dent Res 87, 328–333. doi:10.1177/154405910808700421.
3. Demmer, R. T., Desvarieux, M., Holtfreter, B., Jacobs, D. R., Jr., Wallaschofski, H., Nauck, M., Volzke, H. & Kocher, T. (2010)
Periodontal status and A1C change: longitudinal results from the study of health in Pomerania (SHIP). Diabetes Care 33, 1037–1043.
doi:10.2337/dc09-1778.
4. Demmer, R. T., Jacobs, D. R., Jr. & Desvarieux, M. (2008) Periodontal disease and incident type 2 diabetes: results from the First National
Health and Nutrition Examination Survey and its epidemiologic follow-up study. Diabetes Care 31, 1373–1379. doi:10.2337/dc08-0026.
5. Ide, R., Hoshuyama, T., Wilson, D., Takahashi, K. & Higashi, T. (2011) Periodontal disease and incident diabetes: a seven-year study.
J Dent Res 90, 41–46. doi:10.1177/0022034510381902.
6. Li, Q., Chalmers, J., Czernichow, S., Neal, B., Taylor, B. A., Zoungas, S., Poulter, N., Woodward, M., Patel, A., de Galan, B., Batty,
G. D. & ADVANCE Collaborative Group. (2010) Oral disease and subsequent cardiovascular disease in people with type 2 diabetes: a
prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled
Evaluation (ADVANCE) trial. Diabetologia 53, 2320–2327. doi:10.1007/s00125-010-1862-1.
7. Morita, I., Inagaki, K., Nakamura, F., Noguchi, T., Matsubara, T., Yoshii, S., Nakagaki, H., Mizuno, K., Sheiham, A. & Sabbah, W.
(2012) Relationship between periodontal status and levels of glycated hemoglobin. J Dent Res 91, 161–166. doi:10.1177/0022034511431583.
8. Morita, T., Yamazaki, Y., Mita, A., Takada, K., Seto, M., Nishinoue, N., Sasaki, Y., Motohashi, M. & Maeno, M. (2010) A cohort study
on the association between periodontal disease and the development of metabolic syndrome. J Periodontol 81, 512–519. doi:10.1902/jop.
2010.090594.
9. Noma, H., Sakamoto, I., Mochizuki, H., Tsukamoto, H., Minamoto, A., Funatsu, H., Yamashita, H., Nakamura, S., Kiriyama, K.,
Kurihara, H. & Mishima, H. K. (2004) Relationship between periodontal disease and diabetic retinopathy. Diabetes Care 27, 615.
doi:10.2337/diacare.27.2.615.
10. Saito, T., Shimazaki, Y., Kiyohara, Y., Kato, I., Kubo, M., Iida, M. & Koga, T. (2004) The severity of periodontal disease is
associated with the development of glucose intolerance in non-diabetics: the Hisayama study. J Dent Res 83, 485–490.
doi:10.1177/154405910408300610.
11. Saremi, A., Nelson, R. G., Tulloch-Reid, M., Hanson, R. L., Sievers, M. L., Taylor, G. W., Shlossman, M., Bennett, P. H., Genco, R. &
Knowler, W. C. (2005) Periodontal disease and mortality in type 2 diabetes. Diabetes Care 28, 27–32. doi:10.2337/diacare.28.1.27.
12. Shultis, W. A., Weil, E. J., Looker, H. C., Curtis, J. M., Shlossman, M., Genco, R. J., Knowler, W. C. & Nelson, R. G. (2007) Effect of
perio-dontitis on overt nephropathy and end-stage renal disease in type 2 diabetes. Diabetes Care 30, 306–311. doi:10.2337/dc06-1184.
13. Southerland, J. H., Moss, K., Taylor, G. W., Beck, J. D., Pankow, J., Gangula, P. R. & Offenbacher, S. (2012) Periodontitis and diabetes
associations with measures of atherosclerosis and CHD. Atherosclerosis 222, 196–201. doi:10.1016/j.atherosclerosis.2012.01.026.
14. Taylor, G. W., Burt, B. A., Becker, M. P., Genco, R. J., Shlossman, M., Knowler, W. C. & Pettitt, D. J. (1996) Severe periodontitis and
risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol 67, 1085–1093. doi:10.1902/jop.1996.
67.10s.1085.
15. Thorstensson, H., Kuylenstierna, J. & Hugoson, A. (1996) Medical status and complications in relation to periodontal disease experience in
insulin-dependent diabetics. J Clin Periodontol 23, 194–202. doi:10.1111/j.1600-051X.1996.tb02076.x.
16. Xiong, X., Elkind-Hirsch, K. E., Vastardis, S., Delarosa, R. L., Pridjian, G. & Buekens, P. (2009) Periodontal disease is associated with
gestational diabetes mellitus: a case-control study. J Periodontol 80, 1742–1749. doi:10.1902/jop.2009.090250.
© 2013 European Federation of Periodontology and American Academy of Periodontology
Effect of periodontal disease on diabetes: review S139
corresponding by topic to the results
tables included in this main report.
All studies were conducted among
adults.
1. Do people with manifest type 2
diabetes; pre-diabetes; or no known
diabetes, who have poorer periodontal
health, have poorer glycaemic control
than those with better periodontal
health? (E1)
Brief summary of characteristics and
results
Table 2 displays a summary of the
four studies identified. No eligible
study was conducted among subjects
with baseline pre-diabetes (Eligibility
Category E1b), so only reports on
studies among participants with
either manifest type 2 diabetes (E1a)
or no known diabetes (E1c) at base-
line were included.
Of the four studies, three were of
prospective and one retrospective
cohort design. They included 4512
participants ages 18–81 years in
three countries (Germany, Japan
and USA). Clinical periodontal
examination results were reported
based on periodontal probing depth
(PPD), clinical attachment loss
(CAL), gingival bleeding and num-
ber of teeth present. Radiographic
examination in one study assessed
per cent bone loss. Glucose measures
included glycosylated haemoglobin
(HbA1c) as well as fasting and 2-h
75 g plasma glucose level, and oral
glucose tolerance test (OGTT).
One study was conducted among
individuals with type 2 diabetes
(Taylor et al. 1996) and three in peo-
ple without diabetes at baseline (Sai-
to et al. 2004, Demmer et al. 2010,
Morita et al. 2010). The former
included American Indians of the
Gila River Indian Community (Pima
Indians) and demonstrated that
severe periodontitis was associated
with poor glycaemic control after a
5-year period. Those with CAL of at
least 6 mm had over six times the
risk of poor glycaemic control com-
pared to those without; and individ-
uals 35 years and younger at
baseline with radiographic bone loss
of at least 50% of the root length
had 4.2–13.6 times the risk of poor
control (Taylor et al. 1996).
Over a 4-year period, initially sys-
temically healthy Japanese employ-
ees with periodontal disease were in
a dose–response manner more likely
to develop metabolic syndrome (that
includes hyperglycaemia) than those
periodontally healthy (Morita et al.
2010).
In large population studies in Ger-
many and Japan, the former found
that after five years, an increase in
mean CAL, but not in PPD, was
associated with an increase in HbA1c
(Demmer et al. 2010). In addition,
individuals with a healthy periodon-
tium at both baseline and follow-up
had less HbA1c increase than those
with poor baseline and 5-year deterio-
ration in periodontal health (0.005
versus 0.143%; p = 0.003).
However, the latter demonstrated
after 10 years a significant increase in
impaired glucose tolerance (IGT)
with mean PPD, but not CAL, with
each additional millimetre mean PPD
corresponding to 0.13% increase in
HbA1c (Saito et al. 2004).
Quality assessment
All studies used multivariate analy-
ses, and all controlled for age and
smoking, except for one study (Tay-
lor et al. 1996). All four studies
earned eight or nine of the nine pos-
sible stars in the NOS quality rating
as shown in Appendix S10.
Major weaknesses
There were very few studies. They
were conducted only in Germany,
Japan and USA and were not gener-
alizable. All clinical studies used par-
tial mouth periodontal examinations.
Periodontal and metabolic outcome
parameters varied.
2. Do people with type 1 diabetes,
who have poorer periodontal health,
have poorer glycaemic control than
those with better periodontal health?
No studies were found eligible
(E2).
3. Do people with diabetes, who have
poorer periodontal health, have more
diabetes-related complications than
those with better periodontal health?
Brief summary of characteristics and
results
The seven studies are summarized in
Table 3 (E3). They were conducted
in Brazil, Japan, Sweden, USA (3) and
in 20 different countries respectively.
Four were of cohort and three of
cross-sectional design. Only one study
focused on type 1 diabetes, five studied
type 2 diabetes, and one did not spec-
ify diabetes type. A total of 18,397
subjects participated, ranging from 39
to 10,958, with five of the studies
combined including 1391 persons.
Participants were at least 25 years
old.
Clinical periodontal examination
results were reported based on PPD
and CAL, bleeding on probing; and
number of teeth present. Radio-
graphic examinations assessed per
cent bone loss. In the multi-country
study, self-reported number of teeth
present and number of days with gin-




proteinuria and end-stage renal dis-
ease); neuropathic foot ulceration;
cardiovascular disease (coronary
heart disease, ischaemic heart disease,
carotid intima media thickening and
calcification of atherosclerotic pla-
que); cerebrovascular events (stroke);
and death due to cardiorenal disease.
In the study among people with
type 1 diabetes, all cardiorenal
complications, but not retinopathy,
were significantly associated with
periodontal disease (PD). All studies
in subjects with types 1 and 2 diabe-
tes found that those with periodontal
disease, especially severe disease, and
edentulism, had higher risk for dia-
betes-related complications than par-
ticipants without or with mild
periodontal disease. A dose–response
effect was seen between severity of
periodontal disease and complica-
tions. For instance, moderate and
severe PD, as well as edentulousness
significantly predicted both macroal-
buminuria and end-stage renal dis-
ease in a dose-dependent manner
among Pima Indians (Shultis et al.
2007). In this population, those with
severe PD had 3.5 times higher risk
for cardiorenal death; moreover,
nephropathy and death from ischae-
mic heart disease were significantly
predicted by PD (Saremi et al.
2005).
Quality assessment
Two studies used full-mouth and
four partial mouth clinical peri-
odontal examinations, and radio-
graphic bone loss assessment was
performed in four studies, of which
three used all teeth. The seventh
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BL DM Type 
A) # Subjects: 
a. Perio Cases 
b. Comparison 
 group(s) 
B) Age  

















Odds Ratio (OR), Trend 
& 
Significance (95%CI) 












74F), incl. 88 
 w/>2 exams 
A2) Clin. Exams: 
N=89(27M+62F)  
B) All >18yrs 
[18-67yrs] 
C1) X-ray Exams: 
2.4yrs [2-4yrs] 
C2) Clin. Exams: 
5yrs 
Partial mouth 
(6 index teeth) 
PPD 
CAL 
X-ray bone loss 
PD@BL: >1 tooth with:
1) X-ray bone loss  
≥50%  
or 







Yes, stat. sign. in 
Pima American 






OR for Poor Glycaemic Control 
by Baseline Age:
1) Bone Loss: 
25yrs: OR=13.6 (1.7- 106.0) 
30yrs: OR=7.3 (1.5-38.2) 
35yrs: OR 4.2 (1.2- 14.9) 
40yrs: OR=2.3 (0.8-6.8) 
45yrs: OR=1.3 (0.4–4.0) 
50yrs: OR=0.7 (0.2–2.9) 
2) CAL:
Severe vs. no periodontitis:  
OR=6.2 (1.5–25.3) 
Severe periodontitis was 
associated with poor 
metabolic control in 
type 2 diabetes after 2 
to 5 years 
1)Bone loss:
Age 







COMMENTS: Good examiner calibration agreement for clinical & radiographic examinations 
COMMENTS: No examiner calibration; Dose-response effect stat. sign for trend; CPI is a poor measure of PD 
E1c. No Diabetes:








B) 37.3yrs  
[20-56yrs] 
C) 4yrs 
Partial mouth (sextants) 




3: >1 PPD 4-5mm 
4:>1 PPD> 6mm 
PD Groups:
















OR=1.6 (1.1-2.2; p<0.05) for >1 
positive MetS component vs. 
no positive MetS component 
in PD; OR=1.4 (1.0-2.1) for 
>1; OR=2.2 (1.1-4.1) for >2 
MetS components 
In initially healthy indi-
viduals, periodontal 
disease is associated in a 
dose-response manner 
with development of >1 
components of metabolic 








weight at BL 
Multivariate 




































1) BL # teeth was not 
consistently associated with 
5yr change in HbA1c 
(ptrend=0.84) 
2) Those perio healthy at BL & 
FU had less 5yr HbA1c 
change than those w/poor BL 
perio health and 5yrs perio 
deterioration: 0.005 vs.
0.143% (p=0.003) 
5-year change in mean 
CAL (but not in mean 
















Table 2. Effect of periodontal disease on metabolic control in subjects with type 2 diabetes or without diabetes (E1a & E1c)
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study relied on self-report only. The
large international study states the
participants were representative of
people with type 2 diabetes. It used
a non-traditional definition of oral
health status, stating that “Lower
numbers of natural teeth and higher
numbers of days of gum bleeding
indicated poorer oral health,”
deducted exclusively from self-
report by asking about the partici-





BL DM Type 
A) # Subjects: 
a. Perio Cases 
b. Comparison 
 group(s) 
B) Age  

















Odds Ratio (OR), Trend 
& 
Significance (95%CI) 





Used 3 additional PD 
groupings based on:
1) BL PPD  
2) BL # teeth 








COMMENTS: Study of Health In Pomerania (SHIP); *right or left side of mouth; Good to excellent agreement in intra- and inter-examiner periodontal exam calibration  






All without DM 
@BL in 1988 




among N1 aged 
>40yrs in 1988 
N3=545 w/HbA1c 
values both at 
BL and FU 
A) 40-79 yrs 







a2) Deep/High: >2.0mm 




a2) High: >2.5mm 
b) Low: <1.5mm 




























1) High vs.Low PPD categories:  
OR=2.4 (1.4-2.6; p= 0.009) for 
risk of IGT 
2) No sign. increase in IGT with 
mean CAL 
1) Proportion w/IGT 
increased significantly 
w/mean PPD 
2) Those w/normal BL GT 
who developed IGT over 
10 years were sign. more 
likely to have deep 
PPD, but not CAL, at FU 
3) Each additional mm 
mean PPD corre-
sponded to 0.13% 
HbA1c increase 
(p=0.007) 
4) Severity of perio-dontal 
disease expressed as 
PPD, but not CAL, was 
sign. associated with 







• alcohol  
COMMENTS: *May be regarded as 1998 cross-sectional exam plus 1988 OGGT data, i.e., oral health data only from 1998 (not from BL 1988); **NHANES III protocol (1 max. + 1 mand. quadrant); 
4 “trained” examiners; No calibration reported   
Table 2. (continued)
BP, Blood Pressure; CPI,Community Periodontal Index; Excl.,Excluding/Excluded; MetS, Metabolic Syndrome; Perio, Periodontal/Peri-
odontally; #, Number (of); &, and; BL, Baseline/Beginning of Study Period; CAL, Clinical Attachment Loss; CI, Confidence Interval; CPI,
Community Periodontal Index; DM, Diabetes Mellitus; DM2, Type 2 Diabetes Mellitus; F, Female; FU, Follow-Up/End of Study Period;
GT, Glucose Tolerance; HbA1c, Glycosylated(Glycated) Haemoglobin; hr, hour; HR, Hazard Ratio; hsCRP, high-sensitivity C-reactive pro-
tein; IGT, Impaired Glucose Tolerance; M, Male; NGT, Normal Glucose Tolerance; NHANES, National Health and Nutrition Examina-
tion Survey; OGTT, Oral Glucose Tolerance Test; OR, Odds Ratio; Perio/PD, Periodontal Disease; PPD, Periodontal Probing (Pocket)
Depth; RR, Risk Ratio; Stat. sign., statistically significant; vs., versus; yr(s), Year(s).
© 2013 European Federation of Periodontology and American Academy of Periodontology
S142 Borgnakke et al.







A) #  Subjects: 
a. Perio Cases 
b. Comparison group(s) 
B) Age 
















HR, HRR, OR 
& 
Significance (95%CI) 











A) N@FU=39(21M +18F) 
w/DM1 
B) 55 yrs [36–70] 








bone loss >1/3 root length 
No PD may have:
gingivitis 
PDP 




















Proteinuria: p< 0.05 
Stroke: p< 0.01 
Angina: p<0.001 
TIA: p< 0.05 
MI: p< 0.01 
Heart failure: p< 0.01 
Intermittent claudication:  
p< 0.01 
Retinopathy: ns 
EKG abnormalities: ns 
People with type 1 diabetes 
and periodontal disease 
have more renal and 
cerebro-cardiovascular 
diabetes complications 




Type 2 Diabetes: 





A) N=628(406M+222F)  
w/DM2 
B) All >35 yrs:
a1) Moderate: 47 (+10) yrs 
a2) Severe Perio: 55 (+11) yrs 
b) No/Mild: 43 (+7) yrs 
C) 11 yrs[0.3-16yrs] 
1) CAL: 4 sites/ 6 index teeth 
2) Bone Loss: Panoramic X-
ray/All teeth 
3) # teeth 
PD:
a1) Moderate: >15 teeth;  
median bone loss 50-75% 
or median CAL 2-5mm 
a2) Severe: <15 teeth; 
 median BL > 75% or 
 median CAL >6mm  
b) No/mild: >15 teeth;  





Yes, stat. sign. in 
Pima 
American 
Indians in  







Death due to cardio-renal 
disease rate ratio for severe 




4.5 (2.0-10.2; p<0.01) 
Model 2:
3.5 (1.2-10.0; p=0.02) 
Subjects with DM2 and 
periodontal disease have a 
higher death rate from 
cardio-renal disease* than 
those without periodontal 
disease 
Among subjects with 
DM2, PD significantly 
















COMMENTS: *Most likely DM1, deducted from report; No examiner calibration reported; Dose-response effect not tested; **Partially controlled by study design
COMMENTS: *cardio-renal disease = ischemic heart disease (IHD) & diabetic nephropathy combined; Good intra- & inter-examiner calibration agreement for clinical & radiographic examinations (as per personal communication with authors);
72% of extractions due to PD, therefore edentulism regarded as most severe form of PD
median BL<50%and 










A) N=529(168M+361F)  
 w/DM2 
a1) Moderate Perio:  
200(80M+120F) 
a2) Severe Perio:  
117(39M+78F) 
a3) Edentulous:  
105(25M+80F) 
b) No/Mild Perio:  
107(24M+83F) 
B) All >25yrs [25-79yrs]: 
a1) 44yrs [25-72yrs] 
a2) 49yrs[26-77yrs] 
a3) 55yrs [25-79yrs] 
b) 33yrs [25-72yrs] 
1) CAL: 4 sites/ 6 index teeth 
2) Bone Loss: Panoramic
 X- ray/All teeth 
3) # teeth 
PD:
a1) Moderate: >15 teeth; <7 
teeth w/ 50-74% bone loss 
&<4 teeth w/>75% bone 
loss 
a2) Severe: <15 teeth or 
greater bone loss than 
no/mild and moderate 
a3) Edentulous 
b) No/mild: >24 teeth; 
<6 teeth w/25-49% bone 
macroalbumin-
uria (MA): n=193 
end stage renal 
disease (ESRD):  
n=68 
Yes, stat. sign. in 
Pima American 







Severe vs. no/mild PD: 
HRR=2.1(1.2–3.8) 
Moderate vs. no/mild PD: 
HRR 2.0 (1.2 – 3.5) 
Edentulous vs. no/mild PD: 
HRR 2.6 (1.4 – 4.6) 
Overall p=0.01 
ESRD:
Severe vs. no/mild PD: 
HR=3.5(0.96-12.4) 
Moderate vs. no/mild PD: HR 
2.3 (0.6–8.1) 
Edentulous vs. no/mild PD: 
HRR 4.9 (1.4–17.4); 
Moderate & severe PD as 
well as edentulism each 
significantly predicted 
both macroalbuminuria 
(MA) and end stage renal 
disease (ESRD) in a dose-
dependent manner 








Table 3. Effect of periodontal disease on diabetes complications (E3)
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A) #  Subjects: 
a. Perio Cases 
b. Comparison group(s) 
B) Age 
















HR, HRR, OR 
& 
Significance (95%CI) 








C2) End Stage Renal  
Disease:14.9yrs [0.03–
21.8yrs] 
loss and <4 teeth w/>75% 
bone loss 
Overall p=0.02 
COMMENTS: Good intra- & inter-examiner calibration agreement for clinical & radiographic examinations (as per personal communication with authors); *Smoking & PD status updated at each examination; **Insignificant in models also
adjusted for HbA1c; 72% of extractions due to PD, thus edentulism regarded as most severe form of PD
COMMENTS: Action in Diabetes and Vascular Disease: Preterax and Diami-cron Modified-Release Controlled Evaluation (ADVANCE) study; *Dichotomized values >0 at median to create cate-gories (0, 1–21, ≥22 teeth  &0, <12, ≥12 days);   
Dose response effect for number of teeth, but not bleeding gums; Inadequate assessment of periodontal condition: Non-validated, non-standard self-report items used; no clinical or radiologic periodontal examination; No knowledge of reason for
tooth loss;  may not be due to PD; may not be alike in the 20 countries/215 centres   
COMMENTS: Not controlled for metabolic control; Mean DM duration= 14.5(+9.6)yrs [1–40yrs]; Mean HbA1c=9.3(± 2.2)% [4.9–14.7%]  




A1) N@BL=11,140  




number of natural teeth 
number of days gums bled 





Yes, number of 
natural teeth in 
most cases 
associated stat. 
# Natural Teeth: 
I) CHD events:
1) HR=1.24 (0.98–1.56) for 1-
21 vs.>22 teeth 
Number of teeth associated 
weakly with 
cardiovascular mortality 







a1) 1–21 teeth: 4,174 
a2)  0 teeth: 2,308 
b) ≥22 teeth: 4,476 
2) # in Groups by #Days 
w/BleedingGums/1yr: 
a1) <12 days/1yr: 686 
a2) ≥12 days/1yr:719 
b) 0 days/1yr: 9,553 
B) 65.8(+6.4)yrs[55-88yrs]
1) Age by Natural Teeth*:
a1)1–21 teeth:6.3(+6.2) 
a2) 0 teeth:68.6(+6.4)yrs 
b) ≥22 teeth: 63.9(+5.9) 






Mortality sign with out-













type 2 diabetes 
2) HR=1.04 (0.81-1.23) for 0 
vs.>22 teeth. 
P=0.34 for trend 
II) Cerebro-vascular events:
1) HR=1.24 (1.03-1.49) for 1-21 
vs.>22 teeth 
2) HR=1.10 (0.87-1.38) for 0 
vs.>22 teeth; 
P=0.29 for trend 
III) CVD mortality:
1) HR= 1.32 (1.06-1.65) for 1-
21 vs.>22 teeth 
2) HR=1.35 (1.05-1.74) for 0 
vs.>22 teeth; 
P=0.02 for trend 
IV) # Days of Bleeding 
Gums/1Year: Association 
with cerebrovascular 
outcomes somewhat weaker 
& statistically non-significant 
cerebrovascular events in 
men and women with 
DM2 




with cardio- & 
cerebrovascular events & 
mortality 
ethnicity 

























a2) Edentulous:  
n=34 (27.8%) 
b) No/Mild:=49 (40.2%) 
B) 60.5(+10.5)yrs 
[27.9-80.6yrs] 
C) n/a (cross-sectional) 
CPI (ging./BOP/PPD) 
PD:
a1) Moderate/ Severe:  
CPI codes 3 or 4 
a2) Edentulous due to  
PD 
b) No/Mild: CPI= 0, 1, 2  
pathic foot 
ulceration 
Not generalisable OR=4.9 (1.6- 15.3;  
p<0.01) 
Moderate/ Severe vs. No/Mild:
OR=6.6 (2.3-18.8;  
p<0.001) 
associated with risk for 






Abrao et al. A)N=122 (53M+69F) w/DM2 Partial mouth Exam Risk for neuro- Yes, stat. sign. Edentulous vs. No/Mild: Periodontal status was DM duration 
Table 3. (continued)
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“number of days their teeth had
bled in the preceding year” (Li
et al. 2010). Using the number of
teeth as an expression of past peri-
odontal disease may not be appro-
priate in all these 20 countries,
without information on the reason
for tooth loss.
All studies regarding type 2 dia-
betes used multivariate analyses to
control for the important confound-
ers displayed in Table 3. Results
were statistically significant after
adjustment.
As seen in Exhibit Appendix S11,
only one study earned the maximum
of nine stars for cohort studies
(Saremi et al. 2005). The four longitu-
dinal studies earned between seven
and nine stars, averaging eight. None
of the three cross-sectional studies
were awarded the maximum six stars
for studies with such design, but two
attained five, and the mean was four
stars. The study of the lowest quality
was included in this review only for
completeness (Li et al. 2010).
Major weaknesses
Only one, small study was conducted
in type 1 diabetes (Thorstensson et al.
1996). No high quality cohort studies
were conducted in samples represen-
tative of individuals with type 2 dia-
betes. Two of the three cohort studies
on type 2 diabetes were conducted in
a special population of Pima Indians,
and the international study did not
use any commonly accepted assess-
ment of periodontal disease. Due to
their design, cross-sectional studies
can provide information regarding
only associations, not causation, and
are thus not able to provide strong
evidence.
4. Do people without known diabetes,







A) #  Subjects: 
a. Perio Cases 
b. Comparison group(s) 
B) Age 
















HR, HRR, OR 
& 
Significance (95%CI) 





COMMENTS: Dental data from Athero-sclerosis Risk in Communities (ARIC) Study; *DM2 as per personal communication w/authors; Excellent to outstanding inter-examiner calibration agreement for PD; **1) thickened carotid IMT
& 2) more advanced atheroma lesions (atherosclerotic plaque calcification measured by acoustic shadowing); Results not controlled for level of glycaemic control            
COMMENTS:  No examiner calibration reported       
DM2* a1) mild/ moderate:  
1to<15% 
a2) severe:>15% 
b) none: 0% 
PD & DM status also 
combined in 6-category 
variable 
3) CHD:  
OR=1.3 (0.9-1.7) 
II) Severe 
PD & DM vs.
c. with: 
1) IMT>1mm: OR=2.2 
(1.4-3.5; p<0.001) 
2) Acoustic shadowing:  
OR=2.5 (1.3-4.6;  
p<0.001) 
3) CHD:OR=2.6  
(1.6-4.2;p<0.001) 
2) Among subjects with 
type 2 diabetes, 
periodontal disease was 
significantly associated 
with subclinical heart 







No PD & No DM asso






A) N =73 
B) Age not stated 
C) n/a (cross-sectional) 
X-ray bone loss 
PD:
a) bone loss >median 
b) bone loss <median 
Retinopathy Yes, stat. sign. 
Not generalisable 
PD sign. associated  
w/diabetic retinopathy: 
OR=2.80; p=0.036 
1) PD sign. assoc. w/ 
diabetic retinopathy: 
OR=2.80; P=0.036 
2) Severity of PD sign. 







C) n/a (cross-sectional) 




2) Acoustic shadowing: OR=1.3 
(1.0-1.9) 









      n2=5,257 w/o DM 






Y es, stat. sign. 
N ot generalisable 
I) Severe PD assoc. with:
1) IMT>1mm:  
OR=1.3(1.0-1.7) 
1) Severe periodontal 
disease was associated 





#, Number (of); &, and; Acoustic Shadowing, Advanced atherosclerotic lesions or plaque formation; Assoc., Association/Associated; BL,
Baseline/Beginning of Study Period; CAL, Clinical Attachment Loss; CHD, Coronary Heart Disease; CI, Confidence Interval; CPI, Com-
munity Periodontal Index; DM, Diabetes Mellitus; DM2, Type 2 Diabetes Mellitus; EKG, Electro Cardiogram; ESRD, End-Stage Renal
Disease; F, Female; FU, Follow-Up/End of Study Period; HRR, Hazard Rate Ratio; HbA1c, Glycosylated (Glycated) Haemoglobin; HDL,
High-Density Lipoprotein; HR, Hazard Ratio; IMT, Intimal-Medial Thickness; M, Male; MA, Macroalbuminuria; ns, non-significant; OR,
Odds Ratio; Perio/PD, periodontal disease; PDP, Pathologically Deepened Pockets; PPD, Periodontal Probing (Pocket) Depth; RR, Risk
Ratio; Stat. sign., statistically significant; vs., versus; w/, with; w/o, without; yr(s), Year(s).
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A) #  Subjects:
a. Perio Cases 
b. Comparison 
    group 
B) Age 
















HR, OR, RR 
& 
Significance (95%CI) 















a1) Moderate: 2,167 
(37.1%) 
(1,511M+656F)  
a2) Severe:490 (8.4%) 
(384M+106F) 
b) No:3,191 (54.6%) 
(1,988M+1,203F) 
B) 30-59yrs;  At FU:
M:43.4(+7.5)yrs;  
F:43.9(+7.5)yrs 
C) 6.5yrs [2-7yrs] 
Partial mouth (sextants) 




3: >1 PPD 4-5mm 
4:>1 PPD> 6mm 
BL CPI Scores:
a1) Mod.: 3 
a2) Sev.: 4 
b) No: 0, 1, or 2 
FPG>125mg/dL  
@ FU 








HR for trend <0.0001
 DM Incidence:
a) No Perio (4.0% DM): 
HR=1(Referent) 
b) Mod.Perio(5.4% DM): 
HR=1.38(1.08-1.78) 
c) Sev.Perio(8.4% DM): 
HR=2.23(1.57-3.17) 
2) Fully Adjusted:
Females only:  
Mod.Perio:  
HR=2.3(1.30-4.08) 
1) Moderate&severe perio 
sign. associated w/DM 
risk (Unadjusted only) 
2) Tendency for increased 
risk, but not sign. after 
adjustment 
3) Females w/mod. perio. 












COMMENTS: 7 “trained” examiners; Intra- & inter-examiner calibration done, but not recorded; Oral exam at BL only; FPG measured 1-6 times 2000-2007; No FU data on n = 2,904 w/oral exam@BL = 33.2%
of original study population; No adjustment for education, income, exercise, medication, co-morbidities        
COMMENTS: *May be regarded as 1998 cross-sectional exam plus 1988 OGGT data, i.e., oral health data only from 1998 (not from BL 1988); **NHANES III protocol (1 max.+ 1 mand. quadrant) 4 “trained”
examiners; No calibration reported    






All without DM @BL in 
1988 
A)@ FU in 1998:
N1=961 (377M+584F); 
N2=591=those among 





















1) High vs. Low PPD 
categories:
Risk of DM:OR=2.6 
(1.3-5.0;p=0.004) 
2) Sign. increase in DM with 
mean CAL 
1) Proportion w/DM 
increased significantly 
w/mean PPD 
2) Each additional mm mean 
PPD corre-sponded to 
0.13% HbA1c increase 
(p=0.007) 
















a2) High: >2.5mm 
b) Low: <1.5mm 
disease (expressed as 
either PPD or CAL) was 
sign. associated with 
development of manifest 
diabetes 





A) N @ BL =11,375 
(40%M+60%F) 




a1) 762 (>0-0.87) 
a2) 761 (0.88-1.60) 
a3) 759 (1.61-2.44) 
NHANES I protocol 
gingival inflammation 
extent 
presence or absence 













Yes, stat. sign. 
in US adults 
Generalisable to 
US adults 
1) Compared to those 
periodontally healthy 
(PI=0), the risk of incident 
DM were:
1a) PD-1#:
OR for PI quintiles 
 w/increasing PD:  
a1) 1.10(0.73-1.64) 
a2) 1.03(0.65–1.63) 
1) The extent of periodontal 
disease (using PD-1) and 
periodontitis (using PD-2) 
were associated with 
incident diabetes 
2) The association of 
periodontal disease (PD-1) 
and periodontitis (PD-2) 
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have greater risk for developing (inci-
dent) type 2 diabetes than those with
better periodontal health? (E6)
Brief summary of characteristics and
results
Three of the four eligible studies dis-
played in Table 4 were conducted in
Japan and one in the USA. Numbers
of participants at the end of the
studies were 12,934 in the former
three and 9296 in the latter, totalling
22,230 individuals. The two largest
Japanese studies included employed
adults aged 30–59 and 30–69, respec-
tively, and the third was community
based among 40–79 year olds. Dem-
mer et al. analysed data representa-
tive of the US population between
25 and 74 years of age (Demmer
et al. 2008).
During study periods of 1–
22 years, three of the four studies







A) #  Subjects:
a. Perio Cases 
b. Comparison 
    group 
B) Age 
















HR, OR, RR 
& 
Significance (95%CI) 





COMMENTS: Data from NHANES 1 [1971-1976 (BL)] & NHEFS 1982-1992 (FU); n = 817 incident DM cases were reported (cumulative incidence = 9%); &) Wu et al. 2000; #) Hujoel et al. 2000 
COMMENTS: *No FU of those who left the workplace during study period; Kappa statistics 0.7-0.9 for calibration of 7 dentist periodontal examiners; Dose-response effect % of BL CPI codes 0, 3,
& 4 w/5yr HbA1c>6.5%: 0.8%, 2.5%, and 3.9% (p = 0.001)     
a5) 760 (5.08-8.0) 
a6) 2,127edentulous 
b) 3,368 (PI=0) 
 (healthy) 
PD-2&#:
a1) 2,135 gingivitis 
for Dentition):
  a1) lowest PI to  
a5) highest PI quintile 
a6) edentulous 





Those with gingivitis had 
40% and those with 
periodontitis 50% increased 
andin never-smoking 
participants 





white blood cell count  
a2) 1,662 perio 





a1) 2,135 gingivitis 
a2) 1,662 perio 
b) 3,372 healthy  
PD-3:




odds of developing DM 
(p< 0.05 for  both) 
1c) Edentulous: 
OR=1.3(1.00-1.70) 
2) PD-3: Dentate with 
advanced tooth loss (25-31 
teeth missing) had 
OR=1.70 (P<0.05) relative 
htootlaminimhtiwesohtot23-42)b
loss (0-8 teeth) 




A)  # @ BL unknown* 













CPI Code 0:  
Healthy gingiva 
CPI Code 3:
>1 PPD= 4-5mm 
CPI Code 4:
>1 PPD> 6mm 






Yes, stat. sign. 
 in employed  





Relative risk (RR) for 
HbA1c≥6.5% at 5yr FU in 
groups w/PPD of 4-5mm 
was 2.47 (0.78-7.79; 
p=0.122) and for those 
w/PPD of >6mm: 3.45 
(1.08-11.02; p=0.037) 
Periodontal disease (pockets 
>6mm) leads to increased 
inci-dence of type 2 







a4) 759 (2.45-5.07) (Mean Score(0-8) a3) 2.08(1.51-2.87) found also in normo-weight total cholesterol 
#, Number (of); &, and; BL, Baseline/Beginning of Study Period; CAL, Clinical Attachment Loss; CI, Confidence Interval; CPI, Community
Periodontal Index; DM, Diabetes Mellitus; F, Female; FPG, Fasting Plasma Glucose; FU, Follow-Up/End of Study Period; HbA1c, Gly-
cosylated(Glycated) Haemoglobin; HDL, High-Density Lipoprotein; hr, hour; HR, Hazard Ratio; M, Male; Mod. , Moderate; NHANES 1,
First National Health and Nutrition Examination Survey; NHEFS, NHANES 1 epidemiologic Follow-up Survey; OGTT, Oral Glucose Tol-
erance Test; OR, Odds Ratio; Perio/PD, Periodontal Disease/Periodontal/Periodontally; PPD, Periodontal Probing (Pocket) Depth; RR,
Risk Ratio; Sev., Severe; Stat. sign., Statistically Significant; vs., Versus; w/o, Without; yr(s), Year(s).
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cant increase in development of
manifest diabetes in people with
severe periodontal disease, deter-
mined by periodontal probing depth,
after adjustment for potential con-
founders (Saito et al. 2004, Demmer
et al. 2008, Morita et al. 2012). In
the fourth, the tendency for
increased risk was not significant
upon adjustment, except in Japanese
employed females with moderate
periodontal disease (Ide et al. 2011).
For instance, those with PPD of
6 mm or greater at baseline had 3.45
times higher risk of developing dia-
betes than those without periodontal
disease (Morita et al. 2012). In the
US population, people with gingivi-
tis had 40% increased odds of devel-
oping diabetes and those with
periodontitis had 50% elevated risk.
In edentulous individuals, the risk
was increased by 30 per cent and
those with advanced, but not
complete, tooth loss had a 70 per
cent increased risk of incident type 2
diabetes. Measured by two different
indices, the association of periodontal
disease with incident diabetes was
found also in individuals who were of
normal weight as well as among peo-
ple who had never smoked cigarettes
(Demmer et al. 2008).
In addition, severity of periodon-
tal disease expressed by clinical
attachment loss at follow-up was sig-
nificantly associated with develop-
ment of diabetes over ten years in
the smallest study (Saito et al. 2004),
in which each additional millimetre
mean PPD corresponded to 0.13%
HbA1c increase (p = 0.007).
Quality assessment
The generally high quality of this
group of large, longitudinal studies
is reflected in the high NOS star
ratings as displayed in Exhibit
Appendix S12, with two earning the
maximum of nine stars, one-eight
and one-seven, averaging 8.3.
Major weaknesses
Eligible studies were performed
exclusively in Japan and the United
States with only one smaller Japa-
nese (Saito et al. 2004) and the
large US (Demmer et al. 2008) stud-
ies being representative of the gen-
eral population. Two were
conducted in Japan among employ-
ees (Ide et al. 2011, Morita et al.
2012). Major concerns regarding the
Japanese work place studies were,
firstly: The oral health examinations
were not conducted for research
and used the Community Periodon-
tal index (CPI) (Ainamo et al.
1982), a quick periodontal assess-
ment of ten index teeth that does
not adequately represent the peri-
odontal health status. Secondly,
employees who left the company
during the study period were not re-
examined at the end. In one study,
it remains unknown how many were
lost to follow-up (Morita et al.
2012); and in the other, a total of
2904 or one-third (33.2%) of the
employees who received oral exams
at baseline were not re-examined at
the end of the study (Ide et al.
2011). Such unknown and large
attrition, respectively, does not lead
to confidence that those remaining
in the study were representative of
those originally examined. Thirdly,
the employees included two to three
times more males than females, and
the analyses were not adjusted for
education level that could be differ-
ent in the two sexes. The Japanese
community-based study included an
oral examination only at follow-up
and therefore did not provide any
knowledge of the periodontal status
at baseline (Saito et al. 2004). This
study could be regarded as a cross-
sectional examination, supplemented
with additional oral glucose toler-
ance test (OGTT) data from ten
years earlier. Even though the
results from the three Japanese
studies were significant, this evi-
dence may not be transferable to
other race/ethnic groups since differ-
ences in fat storage and other fac-
tors may be operative. The national
US study used periodontal inflam-
mation, PPD and number of teeth
present to evaluate the periodontal
health status, whereas CAL was not
assessed.
5. Do women with gestational dia-
betes, who have poorer periodontal
health, have poorer glycaemic control
than those with better periodontal
health? (E4)
AND
6. Do pregnant women, who have
poorer periodontal health, have
greater risk for gestational diabetes
than those with better periodontal
health? (E5)
Brief summary of characteristics and
results
Shown in Table 5 are the only two
eligible small American case-control
studies that examined the effect of
periodontal disease on prevalence of
gestational diabetes (GDM). One
demonstrated that GDM in a dose–
response manner consistently was
associated with clinical PD using
three different PD definitions (Xiong
et al. 2009). The other concluded
that having sites with periodontal
probing depths of 3 mm or greater
was not associated with GDM,
although high vaginal levels of the
periodontal pathogen, Tannerella




One study used full-mouth periodon-
tal probing, applied three PD defini-
tions, and controlled for several
potential confounders (Xiong et al.
2009), whereas the other defined PD
as having at least one site with PPD
of 3 mm or greater and controlled
for only history of GDM. In preg-
nant women, PPD of 3 mm could
represent non-pathological condi-
tions, namely increased probing
depths due to hormonal changes and
oedema. Exhibit Appendix S13 dis-
plays the consensus ratings regarding
the quality of these two studies.
Major weaknesses
There were only two studies, and
they were small, of case-control
design, and conducted among non-
representative samples, making their
findings non-generalizable.
Discussion
Summary of the evidence
Current evidence for effects of peri-
odontal disease on glycaemic control
is scarce. However, it suggests that
compared to periodontally healthy
individuals, people with poor perio-
dontal health and:
• type 2 diabetes or no diabetes:
have greater risk of developing
poorer glycaemic control
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• type 1 or type 2 diabetes:
have greater risk for diabetes-
related complications
• no diabetes:
have greater risk of developing
manifest diabetes.
Results of only two studies
exploring the effect of periodontal
disease on gestational diabetes are
inconclusive.






























Effect on Gestational 
Diabetes 
Conclusion Confounders Controlled 






a. 53 GDM 




Full mouth exam 






>1 PPD >4mm or 
>1 CAL >4mm 
PD2&3:
2 additional PD 
definitions used 
Extent measured by  
PPD & CAL 
50g oral glucose 
challenge test (GCT) 
100g OGTT 
b. Comparison group:
Passed 50g GCT 
No DM of any type 





PD (PPD ≥4mm or 
CAL≥4mm) vs. perio-
dontally healthy:  
OR=2.6  
(1.1-6.1;p=0.014) 




CAL highest quartile vs. 
lowest:  
adj. OR=4.5  
(1.2-16.9; ptrend= 0.007) 
1) Periodontitis was 
consistently associated 
with increased risk of 
GDM, regardless of 
PD definition 
2) There was a dose-
response relationship 
of increased GDM risk 
with increasing 
severity of periodontal 
di-sease, assessed by 
















COMMENTS: Intra- & inter-examiner calibration reported; but only1 dental examiner; PD extent (PPD, CAL) used as continuous & categorical variables; Dose-response effect stat.
sign. for trend; PD (≥1 PPD ≥4 mm or ≥1 CAL ≥4 mm) in 77.4% of GDM vs. 57.5% without GDM: OR = 2.5 (1.2-5.3; p < 0.05)     
COMMENTS: *83% Hispanic Examiner calibration not reported; **Clinical, bacteriological, immunological, and inflammatory mediator parameters assessed 7 weeks prior to
diagnosis of GDM; Prevalence of ≥1 PPD ≥3 mm: 50% in GDM vs. 37% in non-GDM; difference not stat. sign. (p = 0.38)           





A1) N @ BL=268* 
A2) N @ FU=265
pregnant:
a. 22 GDM 
b. 243 non-GDM 
B)  a. 28.7(+5.3)yrs 
b. 26.6 (+5.8)yrs 













1hr, 2hrs, or 3hrs 
Yes:Vaginal 
Tannerella 
forsythia had a 
stat. sign. effect 
on GDM 
Not generalisable 
1) Elevated risk for GDM in 
women with high vaginal 
levels of Tannerella 
forsythia: OR=1.27  
(1.05-1.55; p=0.01). 




not stat. sign. 
3) Having PD (OR=1.68;  
0.52-5.43):  
not stat. sign. 
1) Levels of Tannerella 
forsythia in the vagina, 
but not in the cervix or 
in dental plaque, 
emerged as a risk 
factor for GDM 
2) Having one or more 
sites with periodontal 
probing depth of 3mm 
or more was not a risk 
factor for GDM
Prior GDM 
#, Number (of); &, and; BL, Baseline/Beginning of Study Period; BOP, Bleeding On Probing; CAL, Clinical Attachment Loss; CI, Confi-
dence Interval; DM, Diabetes Mellitus; FU, Follow-Up/End of Study Period; GCT, Glucose Challenge Test; GDM, Gestational Diabetes
Mellitus; Ging., Gingival; hr(s), Hour(s); HR, Hazard Ratio; OGTT, Oral Glucose Tolerance Test; OR, Odds Ratio; Perio/PD, Periodontal
Disease, Periodontal/Periodontally; PPD, Periodontal Probing (Pocket) Depth; RR, Risk Ratio; Stat. sign., Statistically Significant;
T. forsythia, Tannerella forsythia; vs., Versus; yr(s), Year(s).
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Limitations
Study and outcome level
Only 17 reports were eligible for
inclusion in the final review and
included only one study on type 1
and two on gestational diabetes.
Most studies were small, except
those exploring diabetes incidence.
The studies were conducted in a lim-
ited number of countries. A major
limitation in all studies regarding
periodontal disease is the lack of
generally accepted case definitions
for periodontal disease, which
severely impedes or prevents com-
parison of studies (Tonetti & Claffey
2005, Page & Eke 2007, Manau
et al. 2008, Costa et al. 2009, Leroy
et al. 2010). Because both diabetes
and periodontal disease are multifac-
torial, chronic diseases, most studies
were not sufficiently extensive in size,
duration and number or kinds of
parameters to control for all poten-
tially important confounders.
Review level
To maximize comprehension and
interpretation of the findings, only
reports published in the English lan-
guage were included, which may have
excluded potentially valuable evi-
dence. Moreover, we may have over-
looked evidence in English that we
failed to identify, but we succeeded in
retrieving all but one full text article
that, based on the abstract, probably
was a cross-sectional study, and thus
ineligible for inclusion. As with any
scientific evidence, publication bias
resulting from a tendency to preferen-
tially publish positive study findings
may have played a role in creating
the pool of published reports.
Conclusion
Scant current evidence suggests that
periodontal disease adversely affects
glycaemic control and diabetes com-
plications or promotes development
of type 2 diabetes. Consequently,
large-scale, definitive studies of long
duration and in multiple different
population groups in many different
countries are needed in all the areas
this review explored.
Consequences
Should it be possible to demonstrate
an adverse effect of periodontal dis-
ease on glycaemic control, with peri-
odontal disease being a risk factor
for diabetes complications and inci-
dent diabetes, such evidence could
have far-reaching consequences.
Impacted would be patients and fami-
lies, health care providers, insurance
companies, policy-makers and socie-
ties in general, due to the high preva-
lence of both periodontal disease and
diabetes that incurs immense societal,
economic consequences and human
suffering. Controlling and managing
periodontal disease may be a new
alternative to eventually include in
standards for diabetes care. Such shift
in paradigm for management and pre-
vention of diabetes and its complica-
tions may occur in the future.
While waiting for definitive evi-
dence, it may be wise to make efforts
to prevent – and treat to resolution
any existing – periodontal disease, in
order to ensure good health.
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Clinical Relevance
Scientific rationale for the study:
Periodontal disease and diabetes
mellitus are common chronic
diseases occurring worldwide. This
systematic review explored the
epidemiologic, non-experimental,
observational evidence for effects
of periodontal disease on diabetes.
Principal findings: Poor periodontal
health is associated with worsening
of glycaemic control and complica-
tions in diabetes, as well as develop-
ment of type 2 diabetes.
Practical implications: The current,
limited evidence suggests that peri-
odontal disease negatively influences
diabetes outcomes, and that further
longitudinal studies are warranted.
In the meantime, dental care pro-
fessionals should prevent or defini-
tively treat periodontal disease,
especially among patients with dia-
betes.
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